Purchase Order 1333BJ25P00280007

Award Date 8/11/25
Potential Completion Date 8/10/28
Potential Value $867K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lynnfield, MA 01940, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Chemaxon LLC, a foreign-owned for-profit limited liability company, provides annual software licenses for the company's JChem Base, Markush Search, and Marvin for JavaScript products. The $77,800.00 fixed-price purchase order has a completion date of February 1, 2026 and was awarded on January 20, 2023 by the Environmental Protection Agency's (EPA) Office of Research and Development. The contract does not have a small business set-aside designation, reflecting...
This is a $96,520.00 firm fixed-price purchase order contract awarded by the U.S. Environmental Protection Agency's Office of Chemical Safety and Pollution Prevention to Chemaxon LLC, a foreign-owned, for-profit limited liability company, to procure software for a "Chemical Structure Search Tool/Software" project. The contract has no small business set-aside designation. Chemaxon LLC, which specializes in cheminformatics software and services, has a history of providing software...
This is a $113,090.00 firm-fixed-price purchase order awarded by the U.S. Environmental Protection Agency's Office of Chemical Safety and Pollution Prevention to Chemaxon LLC, a foreign-owned, for-profit limited liability company. The contract is for the renewal of an annual maintenance agreement for Chemaxon's Instant JChem Enterprise software, which is used for chemical structure management, analysis, and research. This contract does not have a small business set-aside designation,...
This is a $90,800.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Chemaxon LLC, a foreign-owned for-profit limited liability company. The contract, which has a completion date of September 29, 2023, is for the provision of ChemAxon software licenses, including JChem Oracle Cartridge, Marvin JS, JChem Base, and Instant JChem Enterprise. These specialized...
The U.S. Department of Commerce Patent and Trademark Office (USPTO) awarded a firm fixed price delivery order to Advanced Computer Concepts, Inc. (ACC), a certified woman-owned small business, for ChemOffice Professional software subscription licenses and maintenance. The one-year base period contract, with an additional one-year option period, has a potential value of $605,286.50. This delivery order is under the USPTO General Purpose IT 2015-2022 multiple-award indefinite-delivery,...
This is a firm-fixed-price purchase order for $367,001.56 awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the U.S. Department of Health and Human Services, to Chemaxon LLC. The contract is for the provision of Chemaxon's chemistry software, including products like JChem Oracle Cartridge and Marvin JS, to support NINDS's Preclinical Screening Platform for Pain (PSPP) and Epilepsy Therapy Screening Program (ETSP). The software will enable chemical...
The Environmental Protection Agency (EPA) Office of Chemical Safety and Pollution Prevention (OCSPP) awarded a firm fixed-price purchase order to ChemAxon LLC, a foreign-owned for-profit limited liability company, for the annual software license and renewal fees for the Instant JChem Enterprise Network Service and Support Maintenance Renewal. The potential value of the contract is $113,620.00, and it does not have a set-aside designation. The purchased licenses will allow EPA OCSPP scientists to...
The United States Patent and Trademark Office (USPTO) awarded a Firm Fixed Price purchase order to Biocceleration Inc., a for-profit organization, to renew an expiring contract for operations and maintenance (O&M) services. The contract, valued at $6,263,840.00, has an ultimate completion date of April 30, 2025. The contract is not set aside and is for the continuation of Biocceleration's software and license maintenance services, installation, training, and premier operation support for the...
This is a $146,500.00 purchase order contract awarded by the National Library of Medicine (NLM) to Xemistry GMBH, a foreign-owned for-profit organization, for software support and maintenance of the CACTVS Chemoinformatics Toolkit. The contract has a base period of performance from July 20, 2023 through July 19, 2026, with no set-aside designation. This contract was awarded under the authority of Federal Acquisition Regulation (FAR) Simplified Acquisition Procedures, as Xemistry GMBH is the sole...
Chemaxon LLC has been awarded a $23,865 firm fixed price purchase order by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide Chemaxon software licenses for use across the NIH's Protein Structure Prediction Pipeline and Enhanced Therapeutics Structure Prediction programs through September 2024. The licenses will support the NIH's efforts to advance understanding of neurological disorders and develop new treatments. As the prime contractor,...

This $867,326 firm fixed-price federal contract was awarded by the U.S. Patent and Trademark Office (USPTO), a civilian agency, to Chemaxon LLC for the provision of cheminformatics software and maintenance support. The contract, which does not have a set-aside designation, has an ultimate completion date of August 10, 2028. Chemaxon LLC is a leading provider of specialized chemical analysis and research software, with a history of providing these solutions to various government agencies, including the Department of Health and Human Services and the Environmental Protection Agency. This contract supports the USPTO's needs for managing and analyzing proprietary chemical data, which is critical for initiatives such as the Preclinical Screening Platform for Pain, Epilepsy Therapy Screening Program, and the Addiction Treatment Drug Program Information Management System.

Generated 8/12/25, 12:10 PM